Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
Por um escritor misterioso
Descrição
Neoadjuvant immunotherapy in gastrointestinal cancers – The new standard of care? - ScienceDirect
Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
Episode 1: The Role of Adjuvant and Neoadjuvant Therapy in Melanoma
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial - The Lancet Oncology
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Study shows immunotherapy before and after surgery for advanced melanoma lowers recurrence - UT Health San Antonio
melanoma 2 Minute Medicine
Novel adjuvant options for cutaneous melanoma - ScienceDirect
de
por adulto (o preço varia de acordo com o tamanho do grupo)
